
Eric Olson
Examiner (ID: 2127)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1693 |
| Total Applications | 1713 |
| Issued Applications | 963 |
| Pending Applications | 131 |
| Abandoned Applications | 631 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18518659
[patent_doc_number] => 11708542
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Product comprising polysaccharide derivatives
[patent_app_type] => utility
[patent_app_number] => 16/445613
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20855
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445613
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/445613 | Product comprising polysaccharide derivatives | Jun 18, 2019 | Issued |
Array
(
[id] => 15895331
[patent_doc_number] => 20200147184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => METHODS FOR INTRODUCING MANNOSE 6-PHOSPHATE AND OTHER OLIGOSACCHARIDES ONTO GLYCOPROTEINS AND ITS APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/439665
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16439665
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/439665 | Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and its application thereof | Jun 11, 2019 | Issued |
Array
(
[id] => 14893803
[patent_doc_number] => 20190290667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => MIXTURES OF HMOs
[patent_app_type] => utility
[patent_app_number] => 16/435949
[patent_app_country] => US
[patent_app_date] => 2019-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16435949
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/435949 | Mixtures of HMOs | Jun 9, 2019 | Issued |
Array
(
[id] => 16991736
[patent_doc_number] => 20210230156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => NOVEL HUMAN DIHYDROOROTATE DEHYDROGENASE (hDHODH) INHIBITORS AND THEIR USE IN TARGETING ONCOLOGICAL DISEASES SENSITIVE TO PYRIMIDINE STARVATION
[patent_app_type] => utility
[patent_app_number] => 16/972456
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16972456
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/972456 | Human dihydroorotate dehydrogenase (hDHODH) inhibitors and their use in targeting oncological diseases sensitive to pyrimidine starvation | Jun 5, 2019 | Issued |
Array
(
[id] => 16990135
[patent_doc_number] => 20210228555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => METHOD OF TREATMENT WITH TRADIPITANT
[patent_app_type] => utility
[patent_app_number] => 16/972391
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16972391
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/972391 | METHOD OF TREATMENT WITH TRADIPITANT | Jun 5, 2019 | Abandoned |
Array
(
[id] => 16443642
[patent_doc_number] => 10835546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => App specific BACE inhibitors (ASBIs) and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/433879
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 34689
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16433879
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/433879 | App specific BACE inhibitors (ASBIs) and uses thereof | Jun 5, 2019 | Issued |
Array
(
[id] => 19490520
[patent_doc_number] => 12109204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => Methods for treating muscular dystrophies
[patent_app_type] => utility
[patent_app_number] => 16/972184
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7609
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16972184
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/972184 | Methods for treating muscular dystrophies | Jun 4, 2019 | Issued |
Array
(
[id] => 14864719
[patent_doc_number] => 20190282601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => PHARMACEUTICAL COMPOSITIONS FOR TREATING EBOLA VIRUS DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/430455
[patent_app_country] => US
[patent_app_date] => 2019-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16430455
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/430455 | PHARMACEUTICAL COMPOSITIONS FOR TREATING EBOLA VIRUS DISEASE | Jun 3, 2019 | Abandoned |
Array
(
[id] => 16703124
[patent_doc_number] => 10953037
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-23
[patent_title] => Chondroitin sulfate derivative and agent for treating bladder diseases
[patent_app_type] => utility
[patent_app_number] => 16/427875
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 11790
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16427875
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/427875 | Chondroitin sulfate derivative and agent for treating bladder diseases | May 30, 2019 | Issued |
Array
(
[id] => 16822665
[patent_doc_number] => 20210137958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => PHARMACEUTICAL COMPOSITIONS OF DECITABINE
[patent_app_type] => utility
[patent_app_number] => 16/618342
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16618342
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/618342 | PHARMACEUTICAL COMPOSITIONS OF DECITABINE | May 22, 2019 | Abandoned |
Array
(
[id] => 18202420
[patent_doc_number] => 11584803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Fine cellulose fiber and method for producing same
[patent_app_type] => utility
[patent_app_number] => 17/049825
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6056
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17049825
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/049825 | Fine cellulose fiber and method for producing same | May 16, 2019 | Issued |
Array
(
[id] => 14806201
[patent_doc_number] => 20190269710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => COMPOSITION COMPRISING FUT2-DEPENDENT OLIGOSACCHARIDES AND LACTO-N-NEOTETRAOSE FOR USE IN PROMOTING BRAIN DEVELOPMENT AND COGNITION
[patent_app_type] => utility
[patent_app_number] => 16/415618
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16415618
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/415618 | Composition comprising FUT2-dependent oligosaccharides and lacto-N-neotetraose for use in promoting brain development and cognition | May 16, 2019 | Issued |
Array
(
[id] => 18492325
[patent_doc_number] => 11697736
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-11
[patent_title] => Silicon containing detectable compounds
[patent_app_type] => utility
[patent_app_number] => 16/415700
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 77944
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 285
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16415700
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/415700 | Silicon containing detectable compounds | May 16, 2019 | Issued |
Array
(
[id] => 16991788
[patent_doc_number] => 20210230208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => INORGANIC SALTS OF NICOTINAMIDE MONONUCLOETIDE AS ANTI-AGING AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/055937
[patent_app_country] => US
[patent_app_date] => 2019-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10111
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055937
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/055937 | INORGANIC SALTS OF NICOTINAMIDE MONONUCLOETIDE AS ANTI-AGING AGENTS | May 14, 2019 | Abandoned |
Array
(
[id] => 16640838
[patent_doc_number] => 10918659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Compositions and methods of aloe polysaccharides
[patent_app_type] => utility
[patent_app_number] => 16/402651
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 6146
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16402651
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/402651 | Compositions and methods of aloe polysaccharides | May 2, 2019 | Issued |
Array
(
[id] => 17073713
[patent_doc_number] => 11110092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => Methods of treating hematologic cancers
[patent_app_type] => utility
[patent_app_number] => 16/400414
[patent_app_country] => US
[patent_app_date] => 2019-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10992
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16400414
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/400414 | Methods of treating hematologic cancers | Apr 30, 2019 | Issued |
Array
(
[id] => 14746663
[patent_doc_number] => 20190256505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => PHTHALAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 16/398680
[patent_app_country] => US
[patent_app_date] => 2019-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8948
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16398680
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/398680 | Phthalazinone compounds and methods for the treatment of cystic fibrosis | Apr 29, 2019 | Issued |
Array
(
[id] => 20302483
[patent_doc_number] => 12448461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-21
[patent_title] => ABCB5 ligands and substrates
[patent_app_type] => utility
[patent_app_number] => 17/050424
[patent_app_country] => US
[patent_app_date] => 2019-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12252
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050424
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/050424 | ABCB5 ligands and substrates | Apr 24, 2019 | Issued |
Array
(
[id] => 20227356
[patent_doc_number] => 12415999
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => Nucleic acid isolation and inhibitor removal from complex samples
[patent_app_type] => utility
[patent_app_number] => 17/049742
[patent_app_country] => US
[patent_app_date] => 2019-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 17
[patent_no_of_words] => 15133
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17049742
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/049742 | Nucleic acid isolation and inhibitor removal from complex samples | Apr 16, 2019 | Issued |
Array
(
[id] => 16710471
[patent_doc_number] => 20210077618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => IMMUNIGENIC ALPHA-BRANCHED TREHALOSE-DIESTERS
[patent_app_type] => utility
[patent_app_number] => 17/046595
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046595
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/046595 | Immunigenic alpha-branched trehalose-diesters | Apr 11, 2019 | Issued |